Approval · Notice of Compliance 9396 · 2008
MIACALCIN: Notice of Compliance 9396
Issued February 15, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9396
- Date
- February 15, 2008
- Company
- Novartis Pharmaceuticals Canada Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the product monograph and migration to new format
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIACALCIN | Not yet assigned | — |
Medicinal ingredients
- CALCITONIN (SALMON SYNTHETIC) 200 UNIT per ACT